NCT06269913View on ClinicalTrials.gov

A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

March 12, 2025

Study Completion Date

December 31, 2025

Conditions
Iron Deficiencies
Interventions
OTHER

FeSC

Iron/yeast complex

Trial Locations (1)

T2N4N1

University of Calgary, Calgary

Sponsors

Collaborators (1)

Mitacs
All Listed Sponsors
collaborator

Mitacs

INDUSTRY

collaborator

Natural Sciences and Engineering Research Council, Canada

OTHER

lead

University of Calgary

OTHER

NCT06269913 - A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II | Biotech Hunter | Biotech Hunter